Anavex Life Sciences Corp. Set for TD Cowen Conference Lookahead

A Leap Forward in Environmental Expertise Alright, folks, let's dive into some real grit. Partner Engineering and Science, Inc. has pulled off a neat little trick. They've jumped up 25 spots on the 2026 Engineering News-Record's Top 200 Environmental Firms list. They’ve been making this list for 14 years straight, and that's no fluke. It's a hard road, especially when...

Charting New Territory in Media Excellence You look at a landscape crowded with media agencies, and Ars X Machina (AXM) is really carving out a niche with its no-nonsense, results-driven approach. Not every day, you see a company making good on lofty promises, but here we are, in 2026, and AXM is locking down that Inc. Power Partner accolade for the second year running....

Burger King's Hello Kitty® Move: Fad or Brilliant? Few things scream nostalgia like Hello Kitty® and a Burger King kids' meal. It's the kind of combo that makes you wonder if we're simply riding a wave of kawaii nostalgia or if this is a masterstroke tapping into a multi-generational goldmine. What's in the Box? Burger King isn't playing around. Starting October 20,...

Compassionate Expansion Reflecting Community Needs You talk to just about any family facing the heart-wrenching task of making decisions for a loved one's final farewell, and the story ain't pretty. Pricey packages, pressure to upgrade, and a constant side-eye wondering if they're getting the real deal. For Minnesota Cremation Services, though, this expansion is about...

PetroCal's Double Play in the Real Estate Game When you've been in this game as long as I have, you learn to keep an eye on players who can juggle multiple roles. And that's exactly what PetroCal Associates has pulled off with the Tommy's Express Car Wash project in Orlando. This isn't just another carwash setup, folks. We're talking about integrating into Unicorp...

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Doughnut-Sized Dilemma for Duolingo Investors Falling stock prices are nothing new, but when Duolingo (NASDAQ: DUOL) tumbles 25.49% and a securities fraud class action tags along, eyebrows raise. Folks invested between May 2, 2025, and February 26, 2026, might want to dig deeper. Why? Because the alleged deception has unraveled any potential optimism these shareholders...

Nothing like a green light from the FAA to put a little extra swagger in an aircraft lessor's step, and that's exactly what's happening with Aviation Capital Group (ACG) and their big bet on Boeing's 737-10. It's like the champagne just got popped! This milestone is no minor hurdle. We're talking about the largest addition to the 737 MAX family finally giving an official...

CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...

AEVEX on the Legal Hook: What's Going Down? Look, nobody likes bad news, especially when their pockets feel the pinch. AEVEX Corp. (NYSE: AVEX) kicked up quite the dust cloud when their stock plummeted after a secondary offering—dropping a whopping 16% at first glance, and then an extra seven in the blink of an eye. Timing Is Everything in the Stock Game Set the stage:...

Exciting Developments from Mozart Therapeutics Recent findings from Mozart Therapeutics shine a spotlight on MTX-201, a groundbreaking bispecific antibody designed to treat inflammatory bowel disease (IBD). This innovative therapy selectively binds to CD8 regulatory T cells (Treg), with the potential to effectively eliminate pathogenic CD4 T cells and lessen inflammation,...

Arixa Capital Achieves New Heights in Loan Originations Arixa Capital, a prominent private real estate lender, has officially crossed the impressive milestone of over $7 billion in total loan originations since its establishment. This remarkable achievement underscores the firm's commitment to providing flexible and reliable financing solutions to real estate...

Synaffix and Illumina Join Forces for Breakthrough Technologies Synaffix B.V., a prominent biotechnology company renowned for its innovative clinical-stage bioconjugation platform technology, has announced a licensing agreement with Illumina, Inc., a leader in DNA sequencing technologies. This agreement allows Illumina access to Synaffix's patented metal-free click...

Bristol Myers Squibb Gaining Traction in Colorectal Cancer Treatment Bristol Myers Squibb (NYSE: BMY) has recently secured a significant win by obtaining approval from the European Commission (EC) for its leading immunotherapy combinations. This approval is specifically for the use of Opdivo (nivolumab) combined with Yervoy (ipilimumab) as a first-line treatment option...

Hillary F. Blackburn's Significant New Role The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have made an important announcement. They have appointed Hillary F. Blackburn, PharmD, MBA, as the first pharmacist voting member of the Advisory Committee on Immunization Practices (ACIP). This historic appointment...